COVID-19 Roundup
COVID-19 Roundup
04/19/2023
Jessica Ganga
This COVID-19 roundup includes coverage of the FDA’s amendment to its emergency use authorization of the Pfizer-BioNTech booster for pediatric patients, acute myocardial infection deaths rose during omicron...
04/19/2023
FDA ALERT
FDA ALERT
04/18/2023
Jessica Ganga
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
04/18/2023
Research Summary
Research Summary
04/04/2023
Jessica Ganga
The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.
04/04/2023
COVID-19 Roundup
COVID-19 Roundup
03/29/2023
Jessica Ganga
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
03/29/2023
Research Summary
Research Summary
03/27/2023
Researchers find a strong link between migraine and anxiety, depressive symptoms in children and adolescents.
03/27/2023
Enzyme Replacement Therapy
Enzyme Replacement Therapy
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
Research Summary
Research Summary
03/16/2023
In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.
03/16/2023
Research Summary
Research Summary
03/06/2023
Researchers collected and analyzed skin tape strips used on the forearms of newborns to determine whether certain biomarkers could potentially predict the development of atopic dermatitis in infants.
03/06/2023
Research Summary
Research Summary
02/16/2023
The researchers re-evaluated the effects of vitamin D on asthma exacerbation.
02/16/2023
respiratory syncytial virus
respiratory syncytial virus
01/24/2023
Researchers examined the effectiveness of the monoclonal antibody, nirsevimab, in protecting infants from the respiratory syncytial virus (RSV) and RSV lower respiratory tract infection.
01/24/2023